US Stock Market Move | Pharmaceutical stocks rise against the market trend; Eli Lilly (LLY.US) gains nearly 4%.

On Thursday, US pharmaceutical stocks rose against the market trend. Eli Lilly (LLY.US) gained nearly 4%, with a market capitalization of approximately $1.12 trillion; Pfizer Inc. (PFE.US) rose over 2%; Merck & Co., Inc. (MRK.US) and Johnson & Johnson (JNJ.US) gained nearly 2%; Novartis AG Sponsored ADR (NVS.US) and Novo Nordisk A/S Sponsored ADR Class B (NVO.US) rose over 1%; AI healthcare concept stock Tempus AI (TEM.US) gained nearly 5%. On the news front, Eli Lilly announced the signing of a research and development collaboration and licensing agreement with InnoCare Pharma. The two parties will engage in strategic cooperation in the field of innovative drug research and development. InnoCare Pharma will leverage its proprietary drug discovery platform and extensive research experience to discover and develop up to 5 innovative target projects to address major unmet clinical needs. Under the terms of the agreement, Eli Lilly will pay InnoCare Pharma up to $100 million in upfront and near-term milestone payments. The total potential research, development, and commercialization milestone payments amount to approximately $3.25 billion.